Peter Navarro, White House senior counselor for trade and manufacturing, joins 'Money Movers' to discuss the president signing an executive order aimed at boosting U.S. pharma supply chain.

In his op-ed, Navarro reiterated the claim that India's purchase of Russian oil were funding the Russia-Ukraine war.

White House trade adviser Peter Navarro criticized India's ongoing purchases of Russian oil, claiming it funds Moscow's war in Ukraine. He urged India to align with the U.S. as a strategic partner. This led to increased tariffs on Indian imports.

On Monday, Trump said he would nominate economist E. J. Antoni, a longtime critic of the bureau, as commissioner. Antoni has since faced scrutiny after he suggested the agency suspend its monthly jobs report in an interview with Fox News Digital earlier this month.

In his op-ed for The Financial Times, Navarro termed the increase in India's purchase of Russian oil since the invasion of Ukraine as "opportunistic and deeply corrosive" of a global effort to isolate Russia.

Peter Navarro asked whether he and his colleagues have more “credibility” than the consensus views of mainstream economists. He might not like the answer.

TMTPOST -- U.S. President Donald Trump may inpose Section 232 tariffs on pharmaceutical imports, according to White House trade adviser Peter Navarro.